Company
89bio
We are a clinical-stage biopharmaceutical company dedicated to developing and delivering innovative therapies to treat patients with liver and cardiometabolic diseases.
Also known as 89bio, Inc.
- Status
- Acquiredas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Headquarters
- San Francisco, CA, United States
- Legal name
- 89bio, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
We are a clinical-stage biopharmaceutical company dedicated to developing and delivering innovative therapies to treat patients with liver and cardiometabolic diseases. We are driven to help change the dynamic for patients, and through our experience, know that science is key to breaking this cycle of suboptimal treatments.
About the company
- Status notes
- 89bio, Inc. Announces Agreement to be Acquired by Roche
Products
- Other
- pegozafermin
Exit
- Acquisition
- 2025-09-18
Loading relationship preview